Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isonipecotamides for the treatment of integrin-mediated disorders

Isonipecotamides for the treatment of integrin-mediated disorders

US Patent 7718673 · Granted May 18, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Metalloenzyme inhibitor compounds2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025
Substituted 2-anilinopyrimidine derivatives as EGFR modulators2022
2H-indazole derivatives as CDK4 and CDK6 inhibitors and therapeutic uses thereof2022
Metalloenzyme inhibitor compounds2022
Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(2021
Antifungal compounds2021
2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain can2021
Metalloenzyme inhibitor compounds2021
Metalloenzyme inhibitor compounds2021